A carregar...
ANGI-11. DIRECT GLIOMA BLOOD VESSEL DISRUPTION IMPROVES IMMUNE THERAPY BUT WORSENS ANTI-VEGF THERAPY
Glioblastoma is the most vascularized and aggressive glioma with a median survival of less than 2 years. Despite promising clinical trials inhibiting vascular endothelial growth factor (VEGF) failed to improve patient survival. We used Tie2p/e LV [Tie2-TK-IRIS-GFP] mice which express the conditional...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692382/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.089 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|